MDNA Life Sciences Inc. (a Delaware corporation) Shares of Common Stock Warrants to Purchase Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • April 12th, 2023 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • New York
COMMON STOCK PURCHASE WARRANT MDNA LIFE SCIENCES, INC.Security Agreement • April 11th, 2022 • MDNA Life Sciences, Inc. • Services-commercial physical & biological research • New York
This Warrant is being issued pursuant to that certain Securities Purchase Agreement dated as of September 30, 2021 between the Holder and the Company (the “Securities Purchase Agreement”). In addition to the terms defined elsewhere in this Warrant, capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Securities Purchase Agreement.
MDNA Life Sciences Inc. (a Delaware corporation) Shares of Common Stock Warrants to Purchase Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • April 3rd, 2023 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • New York
COMMON STOCK PURCHASE WARRANT MDNA LIFE SCIENCES, INC.Securities Agreement • January 30th, 2023 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • New York
This Warrant is being issued pursuant to that certain Securities Purchase Agreement dated as of December __, 2022 between the Holder and the Company (the “Securities Purchase Agreement”). In addition to the terms defined elsewhere in this Warrant, capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Securities Purchase Agreement.
WARRANT AGENCY AGREEMENTWarrant Agency Agreement • April 3rd, 2023 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • New York
WARRANT AGENCY AGREEMENT, dated as of [___], 2023 (“Agreement”) between MDNA Life Sciences Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability trust company (the “Warrant Agent”).
12% CONVERTIBLE PROMISSORY NOTE DUE JUNE 1, 2023Convertible Security Agreement • January 30th, 2023 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • New York
THIS 12% CONVERTIBLE PROMISSORY NOTE is one of a series of duly authorized and validly issued 12% Convertible Promissory Notes of MDNA Life Sciences, Inc., a Delaware corporation (the “Company”), having its principal place of business at 2054 Vista Parkway, Suite 400, West Palm Beach, FL 33411, designated as its 12% Convertible Promissory Notes due June 1, 2023 (this Note, the “Note” and, collectively with the other Notes of such series, the “Notes”).
EXHIBIT A SECURITIES PURCHASE AGREEMENT and escrow agreement MDNA Life Sciences, Inc. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 5th, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • Delaware
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made as of the ___ day of _________________, 2018 by and among MDNA Life Sciences, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature page hereto (each a “Purchaser” and together the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 30th, 2023 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December __, 2022, between MDNA Life Sciences, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 11th, 2022 • MDNA Life Sciences, Inc. • Services-commercial physical & biological research • Florida
THIS AGREEMENT ("Agreement") is made this 8th day of January, 2016 by and between MDNA Life Sciences, Inc., a Delaware corporation (the "Company") and Christopher C. Mitton, an individual residing at 118 Cocoplum Circle Royal Palm Beach FL 33411 (Executive).
FIRST AMENDMENT TO DECEMBER 22, 2017 LICENSE AGREEMENTLicense Agreement • August 5th, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances
THIS First Amendment to the December 22, 2017 License Agreement ("First Amendment"), effective as of the date last written below (the "Effective Date"), is made by and between MDNA Life Sciences Inc. ("MDNA") and Laboratory Corporation of America Holdings ("LabCorp"). MDNA and LabCorp may be referred to herein each as a "Party" or collectively as "Parties."
Executive Employment AgreementExecutive Employment Agreement • January 30th, 2023 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • Delaware
THIS AGREEMENT (“Agreement”) is made this 1st day of December, 2022 by and between MDNA Life Sciences, Inc., a Delaware corporation (the “Company”) and Jonathan Mills, an individual residing at 25 Hobart, Whitley Bay, Tyne & Wear, NE26 3TA, UK (Executive).
Dated 2020Lease • April 11th, 2022 • MDNA Life Sciences, Inc. • Services-commercial physical & biological research
SECOND AMENDMENT TO DECEMBER 22, 2017 LICENSE AGREEMENTLicense Agreement • May 31st, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances
THIS Second Amendment to the December 22, 2017 License Agreement ("Second Amendment"), effective as of the date of execution by both parties (the "Effective Date"), is made by and between MDNA Life Sciences Inc. ("MDNA") and ("__"). __ and MDNA may be referred to herein each as a "Party" or collectively as "Parties."
SECOND AMENDMENT TO DECEMBER 22, 2017 LICENSE AGREEMENTLicense Agreement • August 5th, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances
THIS Second Amendment to the December 22, 2017 License Agreement ("Second Amendment"), effective as of the date of execution by both parties (the "Effective Date"), is made by and between MDNA Life Sciences Inc. ("MDNA") and Laboratory Corporation of America Holdings ("LabCorp"). LabCorp and MDNA may be referred to herein each as a "Party" or collectively as "Parties."
LICENSE AGREEMENTLicense Agreement • May 31st, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • Delaware
This License Agreement ("Agreement") is entered into by and between MDNA Life Sciences Inc., a Delaware corporation ("MDNA"), and _____, a Delaware corporation ("__"), as of the 22nd day of December, 2017 (the "Effective Date").
LICENSE AGREEMENTLicense Agreement • August 5th, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • Delaware
This License Agreement ("Agreement") is entered into by and between MDNA Life Sciences Inc., a Delaware corporation ("MDNA"), and Laboratory Corporation of America Holdings, a Delaware corporation ("LabCorp"), as of the 22nd day of December, 2017 (the "Effective Date").
DATED 21 March 2019Lease • August 5th, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances • England and Wales
MDNA LIFE SCIENCES (UK) LIMITED (company number 05386828) whose registered office is at 83 Kingfisher House, Kingsway, Team Valley, Gateshead, Tyne & Wear NE11 OJQ
MDNA LIFE SCIENCES, INC. West Palm Beach, FL 33411Agreement to Convert Deferred Compensation to Common Stock • May 2nd, 2023 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances
You are being sent this letter (the “Letter Agreement”) as you (the “Holder”), as of December 31, 2022 are owed $358,133 of deferred compensation (the “Debt”) by MDNA Life Sciences Inc. (the “Company”).
FIRST AMENDMENT TO DECEMBER 22, 2017 LICENSE AGREEMENTLicense Agreement • May 31st, 2022 • MDNA Life Sciences, Inc. • In vitro & in vivo diagnostic substances
THIS First Amendment to the December 22, 2017 License Agreement ("First Amendment"), effective as of the date last written below (the "Effective Date"), is made by and between MDNA Life Sciences Inc. ("MDNA") and _____ ("_____"). MDNA and _____ may be referred to herein each as a "Party" or collectively as "Parties."
Executive Employment Agreement BETWEEN: MDNA Life Sciences Inc. a corporation duly incorporated under the laws of the State of Delaware, (“MDNA”) - and – Robert Poulter, of Gorham, Ontario, Canada (the "Executive")Executive Employment Agreement • April 11th, 2022 • MDNA Life Sciences, Inc. • Services-commercial physical & biological research • Ontario
DATED 21 March 2019Lease Agreement • April 11th, 2022 • MDNA Life Sciences, Inc. • Services-commercial physical & biological research • England and Wales
MDNA LIFE SCIENCES (UK) LIMITED (company number 05386828) whose registered office is at 83 Kingfisher House, Kingsway, Team Valley, Gateshead, Tyne & Wear NE11 OJQ
